RB
Renier Brentjens
Co-founder
About
Co-founder of Juno Therapeutics. Pioneer of CAR-T cell immunotherapy, first to publish efficacy in adult acute lymphoblastic leukemia. Spent 20+ years at Memorial Sloan Kettering. Winner of 2024 Warren Alpert Prize.
Comments
No comments yet. Be the first to share your take.
Frequently asked
Who is Renier Brentjens?
Co-founder of Juno Therapeutics. Pioneer of CAR-T cell immunotherapy, first to publish efficacy in adult acute lymphoblastic leukemia. Spent 20+ years at Memorial Sloan Kettering. Winner of 2024 Warren Alpert Prize.
What is Renier Brentjens's current role?
Renier Brentjens is currently Co-founder.
Where is Renier Brentjens based?
Renier Brentjens is based in Buffalo, United States.
Profile
About Renier Brentjens
Renier Brentjens is Co-founder. Renier is a founder of Juno Therapeutics. Based in Buffalo, United States. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.